Details of patients with CLL with secondary AIHA (CLL + AIHA)
. | . | . | . | . | . | Autoantibody specificity . | . | Splenomegaly, Rai stage/splenomegaly, length below costal margin . | . | Blood counts at diagnosis and at sampling . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient . | Sex . | Age, y . | RhD +/- . | Coombs IgG . | Coombs C3 . | Rh . | Pan-agglutinin . | . | CLL/AIHA duration, mo . | Hb, g/L . | WBC, 109/L . | Platelets, 109/L . | Previous therapy . | Current therapy, mg/d . | |||
1 | M | 66 | + | +++++ | - | Y | N | II/Tip | 24/24 | 50 | 590 | 100 | Chlorambucil, CHOP | Prednisolone, 5 | |||
113 | 6.7 | 138 | |||||||||||||||
2 | M | 73 | + | +++++ | +++++ | Y | N | III/- | 18/8 | 62 | 5.9 | 193 | Chlorambucil | Prednisolone, 5; Azathioprine, 100 | |||
142 | 42 | 90 | |||||||||||||||
3 | M | 75 | + | ++++ | ++ | Y | N | I/- | 3/3 | 83 | 159 | 228 | None | Prednisolone, 7.5 | |||
114 | 63 | 206 | |||||||||||||||
4 | F | 83 | + | +++++ | - | Y | N | 0/- | 1/1 | 90 | 10.7 | 195 | None | Prednisolone, 40 | |||
96 | 12.8 | 220 | |||||||||||||||
5 | M | 87 | + | + | - | Y | N | II/2 cm | 48/48 | 51 | 35.5 | 53 | None | Prednisolone, 40 | |||
84 | 57 | 99 | |||||||||||||||
6 | M | 68 | + | + | + | Y | N | IV/6 cm | 4/2 | 68 | 366 | 111 | Chlorambucil | Prednisolone, 20 | |||
97 | 166 | 53 | |||||||||||||||
7 | M | 69 | - | +++ | ++ | Y | Y | IV/- | 20/16 | 40 | 240 | 331 | Chlorambucil, CHOP, etoposide, 2 courses fludaribine 15/12 presampling | Prednisolone, 80 | |||
79 | 339 | 130 | |||||||||||||||
8 | F | 82 | - | +++ | ++ | Y | Y | I/- | 98/11 | 78 | 137 | 46 | Chlorambucil | Prednisolone, 5 | |||
119 | 15.5 | 213 | |||||||||||||||
9 | M | 68 | + | ++ | ++ | UA | UA | II/- | 42/36 | 111 | 98 | 205 | Chlorambucil | Chlorambucil, 2.5 | |||
134 | 14.1 | 161 | |||||||||||||||
10 | M | 74 | + | ++ | ++ | UA | UA | I/- | 43/1 | 72 | 78.8 | 260 | None | Prednisolone, 30 | |||
111 | 83.4 | 312 | |||||||||||||||
11 | M | 70 | + | +++ | ++ | UA | UA | IV/6 cm | 74/9 | 48 | 208 | 32 | Chlorambucil Fludarabine 2 courses 2 mo previously | Prednisolone, 60 | |||
52 | 204 | 39 | |||||||||||||||
12 | F | 78 | + | +++ | - | UA | UA | II/5 cm | 234/140 | 67 | 156 | 201 | Prednisolone Azathioprine | None | |||
126 | 30.7 | 104 |
. | . | . | . | . | . | Autoantibody specificity . | . | Splenomegaly, Rai stage/splenomegaly, length below costal margin . | . | Blood counts at diagnosis and at sampling . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient . | Sex . | Age, y . | RhD +/- . | Coombs IgG . | Coombs C3 . | Rh . | Pan-agglutinin . | . | CLL/AIHA duration, mo . | Hb, g/L . | WBC, 109/L . | Platelets, 109/L . | Previous therapy . | Current therapy, mg/d . | |||
1 | M | 66 | + | +++++ | - | Y | N | II/Tip | 24/24 | 50 | 590 | 100 | Chlorambucil, CHOP | Prednisolone, 5 | |||
113 | 6.7 | 138 | |||||||||||||||
2 | M | 73 | + | +++++ | +++++ | Y | N | III/- | 18/8 | 62 | 5.9 | 193 | Chlorambucil | Prednisolone, 5; Azathioprine, 100 | |||
142 | 42 | 90 | |||||||||||||||
3 | M | 75 | + | ++++ | ++ | Y | N | I/- | 3/3 | 83 | 159 | 228 | None | Prednisolone, 7.5 | |||
114 | 63 | 206 | |||||||||||||||
4 | F | 83 | + | +++++ | - | Y | N | 0/- | 1/1 | 90 | 10.7 | 195 | None | Prednisolone, 40 | |||
96 | 12.8 | 220 | |||||||||||||||
5 | M | 87 | + | + | - | Y | N | II/2 cm | 48/48 | 51 | 35.5 | 53 | None | Prednisolone, 40 | |||
84 | 57 | 99 | |||||||||||||||
6 | M | 68 | + | + | + | Y | N | IV/6 cm | 4/2 | 68 | 366 | 111 | Chlorambucil | Prednisolone, 20 | |||
97 | 166 | 53 | |||||||||||||||
7 | M | 69 | - | +++ | ++ | Y | Y | IV/- | 20/16 | 40 | 240 | 331 | Chlorambucil, CHOP, etoposide, 2 courses fludaribine 15/12 presampling | Prednisolone, 80 | |||
79 | 339 | 130 | |||||||||||||||
8 | F | 82 | - | +++ | ++ | Y | Y | I/- | 98/11 | 78 | 137 | 46 | Chlorambucil | Prednisolone, 5 | |||
119 | 15.5 | 213 | |||||||||||||||
9 | M | 68 | + | ++ | ++ | UA | UA | II/- | 42/36 | 111 | 98 | 205 | Chlorambucil | Chlorambucil, 2.5 | |||
134 | 14.1 | 161 | |||||||||||||||
10 | M | 74 | + | ++ | ++ | UA | UA | I/- | 43/1 | 72 | 78.8 | 260 | None | Prednisolone, 30 | |||
111 | 83.4 | 312 | |||||||||||||||
11 | M | 70 | + | +++ | ++ | UA | UA | IV/6 cm | 74/9 | 48 | 208 | 32 | Chlorambucil Fludarabine 2 courses 2 mo previously | Prednisolone, 60 | |||
52 | 204 | 39 | |||||||||||||||
12 | F | 78 | + | +++ | - | UA | UA | II/5 cm | 234/140 | 67 | 156 | 201 | Prednisolone Azathioprine | None | |||
126 | 30.7 | 104 |
Hb indicates hemoglobin; +, positive; -, negative; Y, yes; N, no; Tip, just palpable; CHOP, cyclophosphamide, adriamycin, vincristine, and prednisolone; and UA, unavailable.